RSLS Annual Net Income
-$11.39 M
+$34.83 M+75.36%
31 December 2023
Summary:
As of January 23, 2025, RSLS annual net profit is -$11.39 million, with the most recent change of +$34.83 million (+75.36%) on December 31, 2023. During the last 3 years, it has risen by +$10.24 million (+47.36%). RSLS annual net income is now -499.00% below its all-time high of -$1.90 million, reached on December 31, 2003.RSLS Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RSLS Quarterly Net Income
-$1.58 M
+$14.00 K+0.88%
30 September 2024
Summary:
As of January 23, 2025, RSLS quarterly net profit is -$1.58 million, with the most recent change of +$14.00 thousand (+0.88%) on September 30, 2024. Over the past year, it has increased by +$1.95 million (+55.26%). RSLS quarterly net income is now at all-time high.RSLS Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RSLS TTM Net Income
-$7.07 M
+$1.95 M+21.65%
30 September 2024
Summary:
As of January 23, 2025, RSLS TTM net profit is -$7.07 million, with the most recent change of +$1.95 million (+21.65%) on September 30, 2024. Over the past year, it has increased by +$19.09 million (+72.98%). RSLS TTM net income is now -152.05% below its all-time high of -$2.80 million, reached on March 31, 2005.RSLS TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RSLS Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +75.4% | +55.3% | +73.0% |
| 3 y3 years | +47.4% | +91.1% | +79.8% |
| 5 y5 years | +86.0% | +69.5% | +81.5% |
RSLS Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +82.0% | at high | +95.7% | at high | +90.2% |
| 5 y | 5-year | at high | +84.7% | at high | +95.7% | at high | +90.5% |
| alltime | all time | -499.0% | +86.0% | at high | +95.7% | -152.1% | +91.3% |
ReShape Lifesciences Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.58 M(-0.9%) | -$7.07 M(-21.7%) |
| June 2024 | - | -$1.59 M(-27.3%) | -$9.02 M(-17.4%) |
| Mar 2024 | - | -$2.19 M(+29.2%) | -$10.92 M(-4.1%) |
| Dec 2023 | -$11.39 M(-75.4%) | -$1.70 M(-52.0%) | -$11.39 M(-56.5%) |
| Sept 2023 | - | -$3.53 M(+1.2%) | -$26.16 M(-24.9%) |
| June 2023 | - | -$3.49 M(+31.2%) | -$34.81 M(-14.6%) |
| Mar 2023 | - | -$2.66 M(-83.8%) | -$40.76 M(-11.8%) |
| Dec 2022 | -$46.21 M(-26.8%) | -$16.47 M(+35.1%) | -$46.21 M(-30.4%) |
| Sept 2022 | - | -$12.19 M(+29.0%) | -$66.42 M(-7.7%) |
| June 2022 | - | -$9.44 M(+16.4%) | -$71.93 M(+8.3%) |
| Mar 2022 | - | -$8.12 M(-77.9%) | -$66.39 M(+5.1%) |
| Dec 2021 | -$63.15 M(+191.9%) | -$36.67 M(+107.2%) | -$63.15 M(+80.4%) |
| Sept 2021 | - | -$17.70 M(+353.6%) | -$35.01 M(+55.7%) |
| June 2021 | - | -$3.90 M(-19.9%) | -$22.49 M(+1.3%) |
| Mar 2021 | - | -$4.87 M(-42.9%) | -$22.19 M(+2.6%) |
| Dec 2020 | -$21.63 M(-70.9%) | -$8.54 M(+64.8%) | -$21.63 M(-43.3%) |
| Sept 2020 | - | -$5.18 M(+43.7%) | -$38.15 M(-38.2%) |
| June 2020 | - | -$3.60 M(-16.4%) | -$61.73 M(-16.6%) |
| Mar 2020 | - | -$4.31 M(-82.8%) | -$74.04 M(-0.2%) |
| Dec 2019 | -$74.21 M(-8.6%) | -$25.06 M(-12.9%) | -$74.21 M(-3.4%) |
| Sept 2019 | - | -$28.75 M(+80.6%) | -$76.81 M(+39.5%) |
| June 2019 | - | -$15.92 M(+255.7%) | -$55.06 M(-26.0%) |
| Mar 2019 | - | -$4.48 M(-83.8%) | -$74.39 M(-8.3%) |
| Dec 2018 | -$81.15 M(+140.0%) | -$27.66 M(+294.9%) | -$81.15 M(+28.6%) |
| Sept 2018 | - | -$7.00 M(-80.1%) | -$63.11 M(-4.5%) |
| June 2018 | - | -$35.25 M(+213.8%) | -$66.09 M(+75.4%) |
| Mar 2018 | - | -$11.23 M(+16.8%) | -$37.68 M(+11.4%) |
| Dec 2017 | -$33.82 M(+44.8%) | -$9.62 M(-3.8%) | -$33.82 M(+18.1%) |
| Sept 2017 | - | -$9.99 M(+46.1%) | -$28.64 M(+13.8%) |
| June 2017 | - | -$6.84 M(-7.1%) | -$25.16 M(+7.9%) |
| Mar 2017 | - | -$7.37 M(+66.1%) | -$23.32 M(-0.2%) |
| Dec 2016 | -$23.36 M(-8.4%) | -$4.43 M(-32.0%) | -$23.36 M(-9.1%) |
| Sept 2016 | - | -$6.52 M(+30.6%) | -$25.70 M(+10.2%) |
| June 2016 | - | -$5.00 M(-32.6%) | -$23.32 M(-9.4%) |
| Mar 2016 | - | -$7.41 M(+9.4%) | -$25.73 M(+0.9%) |
| Dec 2015 | -$25.50 M(-2.4%) | -$6.77 M(+63.1%) | -$25.50 M(+2.4%) |
| Sept 2015 | - | -$4.15 M(-43.9%) | -$24.91 M(-5.9%) |
| June 2015 | - | -$7.40 M(+3.2%) | -$26.47 M(-0.4%) |
| Mar 2015 | - | -$7.17 M(+16.1%) | -$26.57 M(+1.7%) |
| Dec 2014 | -$26.13 M | -$6.18 M(+8.2%) | -$26.13 M(-1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | -$5.71 M(-23.8%) | -$26.52 M(-2.2%) |
| June 2014 | - | -$7.50 M(+11.4%) | -$27.11 M(+4.5%) |
| Mar 2014 | - | -$6.73 M(+2.4%) | -$25.93 M(+0.6%) |
| Dec 2013 | -$25.78 M(+9.9%) | -$6.57 M(+4.3%) | -$25.78 M(-1.7%) |
| Sept 2013 | - | -$6.30 M(-0.3%) | -$26.23 M(+1.8%) |
| June 2013 | - | -$6.32 M(-3.9%) | -$25.78 M(+5.6%) |
| Mar 2013 | - | -$6.58 M(-6.3%) | -$24.41 M(+4.0%) |
| Dec 2012 | -$23.46 M(-9.8%) | -$7.03 M(+20.2%) | -$23.46 M(-4.2%) |
| Sept 2012 | - | -$5.85 M(+18.0%) | -$24.49 M(-5.6%) |
| June 2012 | - | -$4.95 M(-12.1%) | -$25.94 M(-2.3%) |
| Mar 2012 | - | -$5.63 M(-30.1%) | -$26.54 M(+2.1%) |
| Dec 2011 | -$26.00 M(+49.9%) | -$8.06 M(+10.4%) | -$26.00 M(+18.7%) |
| Sept 2011 | - | -$7.30 M(+31.3%) | -$21.90 M(+15.3%) |
| June 2011 | - | -$5.56 M(+9.3%) | -$18.98 M(+7.3%) |
| Mar 2011 | - | -$5.09 M(+28.6%) | -$17.69 M(+1.9%) |
| Dec 2010 | -$17.35 M(-45.7%) | -$3.96 M(-9.8%) | -$17.35 M(+6.5%) |
| Sept 2010 | - | -$4.39 M(+3.0%) | -$16.28 M(-31.9%) |
| June 2010 | - | -$4.26 M(-10.3%) | -$23.91 M(-20.3%) |
| Mar 2010 | - | -$4.75 M(+64.3%) | -$30.01 M(-6.0%) |
| Dec 2009 | -$31.93 M(-15.7%) | -$2.89 M(-75.9%) | -$31.93 M(-13.4%) |
| Sept 2009 | - | -$12.01 M(+15.9%) | -$36.86 M(+5.2%) |
| June 2009 | - | -$10.36 M(+55.4%) | -$35.05 M(-2.8%) |
| Mar 2009 | - | -$6.67 M(-14.7%) | -$36.05 M(-4.8%) |
| Dec 2008 | -$37.87 M(+32.5%) | -$7.82 M(-23.3%) | -$37.87 M(-2.4%) |
| Sept 2008 | - | -$10.20 M(-10.2%) | -$38.80 M(+10.2%) |
| June 2008 | - | -$11.35 M(+33.6%) | -$35.21 M(+15.6%) |
| Mar 2008 | - | -$8.50 M(-2.8%) | -$30.46 M(+6.6%) |
| Dec 2007 | -$28.58 M(+61.5%) | -$8.75 M(+32.3%) | -$28.58 M(+14.1%) |
| Sept 2007 | - | -$6.61 M(0.0%) | -$25.05 M(+10.9%) |
| June 2007 | - | -$6.61 M(0.0%) | -$22.60 M(+12.2%) |
| Mar 2007 | - | -$6.61 M(+26.5%) | -$20.14 M(+13.9%) |
| Dec 2006 | -$17.69 M(+57.7%) | -$5.22 M(+25.7%) | -$17.69 M(+15.9%) |
| Sept 2006 | - | -$4.16 M(0.0%) | -$15.27 M(+9.7%) |
| June 2006 | - | -$4.16 M(0.0%) | -$13.92 M(+10.8%) |
| Mar 2006 | - | -$4.16 M(+48.2%) | -$12.57 M(+12.0%) |
| Dec 2005 | -$11.22 M(+225.2%) | -$2.80 M(0.0%) | -$11.22 M(+33.3%) |
| Sept 2005 | - | -$2.80 M(0.0%) | -$8.41 M(+50.0%) |
| June 2005 | - | -$2.80 M(0.0%) | -$5.61 M(+100.0%) |
| Mar 2005 | - | -$2.80 M | -$2.80 M |
| Dec 2004 | -$3.45 M(+81.4%) | - | - |
| Dec 2003 | -$1.90 M | - | - |
FAQ
- What is ReShape Lifesciences annual net profit?
- What is the all time high annual net income for ReShape Lifesciences?
- What is ReShape Lifesciences annual net income year-on-year change?
- What is ReShape Lifesciences quarterly net profit?
- What is the all time high quarterly net income for ReShape Lifesciences?
- What is ReShape Lifesciences quarterly net income year-on-year change?
- What is ReShape Lifesciences TTM net profit?
- What is the all time high TTM net income for ReShape Lifesciences?
- What is ReShape Lifesciences TTM net income year-on-year change?
What is ReShape Lifesciences annual net profit?
The current annual net income of RSLS is -$11.39 M
What is the all time high annual net income for ReShape Lifesciences?
ReShape Lifesciences all-time high annual net profit is -$1.90 M
What is ReShape Lifesciences annual net income year-on-year change?
Over the past year, RSLS annual net profit has changed by +$34.83 M (+75.36%)
What is ReShape Lifesciences quarterly net profit?
The current quarterly net income of RSLS is -$1.58 M
What is the all time high quarterly net income for ReShape Lifesciences?
ReShape Lifesciences all-time high quarterly net profit is -$1.58 M
What is ReShape Lifesciences quarterly net income year-on-year change?
Over the past year, RSLS quarterly net profit has changed by +$1.95 M (+55.26%)
What is ReShape Lifesciences TTM net profit?
The current TTM net income of RSLS is -$7.07 M
What is the all time high TTM net income for ReShape Lifesciences?
ReShape Lifesciences all-time high TTM net profit is -$2.80 M
What is ReShape Lifesciences TTM net income year-on-year change?
Over the past year, RSLS TTM net profit has changed by +$19.09 M (+72.98%)